The radiation oncology market share is forecast to reach USD 2,032.03 million, after growing at a CAGR of 4.69% during 2023-2027. The technological advances are analyzed to boost the addiction therapeutics market growth. Moreover, increasing demand for proton therapy is the major trend enhancing the overall market demand for radiation oncology during the forecast period.
Get a snapshot of the radiation oncology market analysis: Unlock the Sample Report
Browse Technavio's 165-page report and in-depth TOC on "Radiation Oncology Market by type (EBRT and brachytherapy), application (breast cancer, lung cancer, penile cancer, prostate cancer, and others), and geography (North America, Europe, Asia, and Rest of World).
View detailed Table of Contents Here: https://www.technavio.com/report/radiation-oncology-market-industry-analysis?v1
EBRT: The radiation oncology market growth by the EBRT segment will be significant during the forecast period. The increasing prevalence of cancer, the increasing preference for minimally invasive and non-invasive treatments, the availability of favorable reimbursements, the increasing adoption of technologically advanced EBRT devices by hospitals and clinics, and increasing awareness about advanced EBRT devices drive the growth of the global EBRT market.
North America: 40% of market growth will develop from North America during the forecast period. The increasing number of regulatory approvals of new products, the increasing adoption of new technologies such as proton beam therapy, and increasing investments by vendors are also major factors influencing the market growth in the region.
The radiation oncology market size will witness a YOY Growth Rate of 3.98% in 2023.
The lack of access to radiotherapy will be a major challenge for the radiation oncology market during the forecast period.
Major key radiation oncology market players include: Accuray Inc., Becton Dickinson and Co., Canon Inc., Carl Zeiss AG, Elekta AB, Hitachi Ltd., iCAD Inc., Ion Beam Applications SA, IsoRay Inc., Mallinckrodt Plc, Mevion Medical Systems Inc., Nordion Canada Inc., Optivus Proton Therapy Inc., Panacea Medical Technologies Pvt. Ltd., RefleXion Medical Inc., Sensus Healthcare Inc., Sumitomo Heavy Industries Ltd., Theragenics Corp., Varian Medical Systems Inc., and ViewRay Inc.
The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as North America, Europe, Asia, and Rest of World (ROW).
Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth.
Precise market size estimation during the forecast period 2023-2027.
CAGR of the radiation oncology market forecast during 2023-2027.
Market-level data on units, average selling prices, and values of the radiation oncology market share.
Prediction of the upcoming trends, drivers, and factors that challenge the growth of the radiation oncology market.
Radiation oncology industry growth across North America, Europe, Asia, and Rest of World.